Chembio Diagnostics Announces 2019 Analyst and Investor Meeting
January 17 2019 - 04:10PM
Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care
diagnostics company focused on infectious diseases, announced today
that it will host an analyst and institutional investor meeting on
Wednesday, February 6, 2019, in New York City from 8:30 a.m. to
approximately 10:30 a.m. Eastern Time.
The meeting will include remarks from members of
the Chembio leadership team on corporate strategy, operational
initiatives, product development, collaborations and trends driving
the business.
The meeting will be broadcast live via the
internet, and a replay of the webcast will be available from 12:00
p.m. Eastern Time on February 6, 2019, through March 14, 2019. The
live and recorded audio webcast of the meeting may be accessed at
www.chembio.com/investors/calendar-of-events/.
About Chembio
DiagnosticsChembio Diagnostics, Inc. is a leading
point-of-care diagnostics company focused on detecting and
diagnosing infectious diseases. The company’s patented DPP®
technology platform, which uses a small drop of blood from the
fingertip, provides high-quality, cost-effective results in
approximately 15 minutes. Coupled with Chembio’s extensive
scientific expertise, its novel DPP® technology offers broad market
applications beyond infectious disease, a number of which are under
active development with collaboration partners. Chembio’s products
are sold globally, directly and through distributors, to hospitals
and clinics, physician offices, clinical laboratories, public
health organizations, government agencies, and consumers.
Headquartered in Medford, NY, Chembio is
registered with the U.S. Food and Drug Administration (FDA) as well
as the U.S. Department of Agriculture (USDA), and is certified for
the global market under the International Standards Organization
(ISO) directive 13485. Learn more at www.chembio.com.
Media contact: |
|
Lynn
Pieper LewisGilmartin Group(415) 937-5402investor@chembio.com |
|
Chembio Diagnostics (NASDAQ:CEMI)
Historical Stock Chart
From Feb 2024 to Mar 2024
Chembio Diagnostics (NASDAQ:CEMI)
Historical Stock Chart
From Mar 2023 to Mar 2024